BSAC Disc Diffusion Method
September 2006, Dr Derek Brown, Chair, BSAC Susceptibility Testing Working Party
Determination of the antimicrobial susceptibility of Neisseria gonorrhoeae
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Newcastle, July 2003
Dr Trevor Winstanley, Sheffield, UK
Surveillance of Resistance
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Newcastle, July 2003
Professor Alasdair MacGowan, Bristol, UK
BSAC rolling programme for devising acceptable limits for control strains
BSAC Standardized Disc Susceptibility Method User Group Day, Newcastle, July 2003
Mrs Jenny Andrews, Birmingham, UK
Detection of beta-lactamase-mediated resistance
BSAC Standardized Disc Susceptibility Method User Group Day, London, November 2003
Dr David Livermore, London, UK
Quality Assurance of Antimicrobial Susceptibility Testing
BSAC Standardized Disc Susceptibility Testing Method User Group Day, London, November 2003
Dr Gunnar Kahlmeter, Vaxjo, Sweden
Recent Changes to the Recommendations
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Cardiff, June 2004
Mrs Jenny Andrews, Birmingham, UK
Veterinary Susceptibility Testing
BSAC Standardized Disc Suscptibility Testing Method User Group Day, Cardiff, June 2004
Mr Christopher Teale, VLA, Shrewsbury, UK
Detection of beta-lactamase-mediated resistance
BSAC Standardized Disc Susceptiblity Testing Method User Group Day, Dublin, October 2004
Dr David Livermore, London, UK
Antimicrobial susceptibility testing in Europe - the role of national breakpoint committees and EUCAST
BSAC Standardized Disc Susceptiblity Testing Method User Group Day, Dublin, October 2004
Dr Gunnar Kahlmeter, Vaxjo, Sweden
Does susceptibility testing have a role in predicting clinical or microbiological outcome?
BSAC Standardized Disc Susceptiblity Testing Method User Group Day, Dublin, October 2004
Professor Alasdair MacGowan, Bristol, UK
Expert rules and inexpensive identification methods
BSAC Standardized Disc Susceptiblity Testing Method User Group Day, Basingstoke, June 2005
Dr Trevor Winstanley, Sheffield, UK
Cefoxitin for the detection of methicillin/oxacillin resistance in staphylococci
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2005
Dr John Perry, Newcastle, UK
Antibacterial drug development
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2005
Professor Alasadiar MacGowan, Bristol, UK
Most often asked questions
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2005
Mrs Jenny Andrews, Birmingham, UK
Expert rules and inexpensive identification methods
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2005
Dr Trevor Winstanley, Sheffield, UK
Confirmation tests for the detection of AmpC
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2006
Dr David Livermore, London UK
Susceptibility testing anaerobes
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2006
Mrs Jenny Andrews, Birmingham, UK
General questions and answers about BSAC methodology
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2006
Mrs Jenny Andrews, Birmingham, UK
Clinical data to support the interpretation of susceptibility testing of anaerobes
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Sheffield, October 2006
Dr Robin Howe, Bristol, UK
Shift to European (EUCAST) breakpoints - the impact on the BSAC recommendations
BSAC Standardized Disc Susceptibility Testing Method User Group Day, London, June 2007
Professor Alasdair MacGowan, Bristol, UK
Susceptibility testing of nucoid Pseudomonas and Burkholderia strains from patients with cystic fibrosis including evaluation of the BSAC Standardized Method
BSAC Standardized Disc Susceptibility Testing Method User Group Day, London, June 2007
Dr John Perry, Freeman Hospital, Newcastle
BSAC recommendations for interpreting the susceptibility of urinary tract isolates
BSAC Standardized Disc Susceptibility Testing Method User Group Day, London, June 2007
Mrs Jenny Andrews, Birmingham, UK
Susceptibility testing new agents eg. linezolid, tigecycline, daptomycin and dalbavancin
BSAC Standardized Disc Susceptibility Testing Method User Group Day, London, June 2007
Dr Ian Morrissey, London, UK
Shift to European (EUCAST) breakpoints - the impact on the BSAC recommendations
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Belfast, November 2007
Dr Derek Brown, Cambridge, UK
Detection of ESBLs and AmpC beta-lactamase
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Belfast, November 2007
Dr David Livermore, London, UK
BSAC recommendations for interpreting the susceptibility of urinary tract isolates
BSAC Standardized Disc Susceptibility Testing Method User Group Day, Belfast, November 2007
Mrs Jenny Andrews, Birmingham, UK
